Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.29 - $0.45 $1,290 - $2,002
-4,450 Reduced 4.48%
94,882 $34,000
Q2 2023

Aug 14, 2023

SELL
$0.52 - $0.91 $146,907 - $257,087
-282,514 Reduced 73.99%
99,332 $52,000
Q1 2023

May 15, 2023

SELL
$0.7 - $1.41 $54,966 - $110,717
-78,523 Reduced 17.06%
381,846 $286,000
Q3 2022

Nov 14, 2022

SELL
$1.22 - $40.8 $640 - $21,420
-525 Reduced 0.11%
460,369 $598,000
Q2 2022

Aug 15, 2022

SELL
$1.15 - $3.34 $124,136 - $360,536
-107,945 Reduced 18.98%
460,894 $737,000
Q1 2022

May 16, 2022

SELL
$2.96 - $7.76 $3.69 Million - $9.67 Million
-1,245,583 Reduced 68.65%
568,839 $1.75 Million
Q4 2021

Feb 14, 2022

SELL
$7.4 - $11.66 $3.16 Million - $4.98 Million
-426,707 Reduced 19.04%
1,814,422 $13.4 Million
Q3 2021

Nov 15, 2021

SELL
$9.18 - $14.15 $1.14 Million - $1.76 Million
-124,514 Reduced 5.26%
2,241,129 $25.9 Million
Q2 2021

Aug 16, 2021

SELL
$8.07 - $12.52 $221,408 - $343,498
-27,436 Reduced 1.15%
2,365,643 $27.6 Million
Q1 2021

May 17, 2021

SELL
$8.57 - $15.79 $9,144 - $16,847
-1,067 Reduced 0.04%
2,393,079 $24.8 Million
Q4 2020

Feb 16, 2021

SELL
$5.98 - $12.47 $178,168 - $371,531
-29,794 Reduced 1.23%
2,394,146 $20 Million
Q3 2020

Nov 16, 2020

BUY
$4.65 - $8.73 $745,934 - $1.4 Million
160,416 Added 7.09%
2,423,940 $14.9 Million
Q2 2020

Aug 24, 2020

BUY
$4.66 - $8.7 $10.5 Million - $19.7 Million
2,263,524 New
2,263,524 $18.9 Million
Q2 2020

Aug 14, 2020

SELL
$4.66 - $8.7 $9.05 Million - $16.9 Million
-1,942,869 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$6.32 - $19.66 $5.13 Million - $16 Million
811,561 Added 71.74%
1,942,869 $27 Million
Q3 2019

Nov 14, 2019

SELL
$8.03 - $14.82 $274,433 - $506,488
-34,176 Reduced 2.93%
1,131,308 $9.49 Million
Q2 2019

Aug 14, 2019

BUY
$11.88 - $16.94 $3.75 Million - $5.34 Million
315,484 Added 37.12%
1,165,484 $15.4 Million
Q1 2019

May 15, 2019

BUY
$17.44 - $17.95 $14.8 Million - $15.3 Million
850,000 New
850,000 $15.3 Million

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $578M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.